Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Sales: 2011-2021

Historic Return on Sales for Neurocrine Biosciences (NBIX) over the last 8 years, with Sep 2021 value amounting to 0.04%.

  • Neurocrine Biosciences' Return on Sales fell 5.00% to 0.04% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.04%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.05% for FY2019, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' Return on Sales is 0.04%, which was down 60.66% from 0.09% recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Return on Sales high stood at 0.20% for Q2 2020, and its period low was -5.25% during Q2 2017.
  • For the 3-year period, Neurocrine Biosciences' Return on Sales averaged around 0.07%, with its median value being 0.07% (2021).
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 509bps in 2018, then decreased by 11bps in 2021.
  • Neurocrine Biosciences' Return on Sales (Quarterly) stood at -0.82% in 2017, then spiked by 87bps to 0.05% in 2018, then remained steady at 0.05% in 2019, then rose by 6bps to 0.09% in 2020, then dropped by 5bps to 0.04% in 2021.
  • Its Return on Sales was 0.04% in Q3 2021, compared to 0.09% in Q2 2021 and 0.09% in Q1 2021.